Research Article

The Seroprevalence of HBsAg, Anti-HBs ve Anti-HCV in Patients Applied Hemodialysis in Rize Province
  • Aysegül ÇOPUR ÇİÇEK
  • Osman Zikrullah ŞAHİN
  • Mustafa Kemal TOPALOĞLU
  • Ayşe Asena TAŞKAYA KAZANCI
  • İsmail Hakkı YENİLMEZ
  • Kazım ŞAHİN
  • Deniz Zehra ULUSAN GÜNDOĞDU
Viral Hepat J 2013; 19: 15-18 DOI: 10.4274/Vhd.14633
Hepatitis C Virus Genotyping by Using Restriction Fragment Length Polymorphism (RFLP) in Anti-HCV Positive Hemodialysis Patients and Renal Transplant Recipients
Viral Hepat J 2005; 10: 28-33
The Evaluation of the Seroprevalence of HBV and HCV Infections in Patients with Hemodialysisin Hatay City and the Assessment of Antibody Response to Hepatitis B Vaccination
  • Ömer EVİRGEN
  • Yusuf ÖNLEN
  • Vicdan KÖKSALDI MOTOR
  • Erkan MAHSERECİ
  • Melek İNCİ
  • Şule ŞAHİN
Viral Hepat J 2010; 16: 57-63
Investigation of HGV-RNA and TTV-DNA Frequency in Hemodialysis Patients
  • Ilhan AFSAR
  • Mehmet TANRISEV
  • Asli Gamze SENER
  • Metin TÜRKER
  • Mustafa CIRIT
Viral Hepat J 2006; 11: 76-79
The Role of Hemodialysis Units in HCV Spread at our Region
  • Emine SÖNMEZ
  • Nedim KIZILKAYA
  • Mustafa ESENTÜRK
  • Mehmet YÜCESOY
Viral Hepat J 1996; 2: 103-108
The seropositivity of HBsAg and HCV of the Patients from Cumhuriyet University Research and Practice Hospital Hemodialysis Unit
  • Özlem KAPLAN
  • Mustafa Zahir BAKICI
  • Cem ÇELİK
  • Mansur KAYATAŞ
  • Ferhan CANDAN
Viral Hepat J 2013; 19: 126-130 DOI: 10.4274/Vhd.88597
HBsAg, Anti-HBs and Anti- HCV Serologic Indicators of the Haemodialysis Unit Workers and Haemodialysis Patients, and Hand Hygiene Compliance Rates of the Workers
  • Serap SÜZÜK
  • Dilek ÖZTAŞ
  • Havva AVCIKÜÇÜK
  • Arzu ÇALIK
Viral Hepat J 2013; 19: 136-139 DOI: 10.4274/Vhd.42713
The Evaluation of the Seroprevalence of HBV, HCV and HIV Infections and the Assessment of Antibody Response to Hepatitis B Vaccination in Hemodialysis Patients
  • Hakan TEMİZ
  • Şafak KAYA
  • Nuh BEREKATOĞLU
  • Sevim TEMİZ
  • Ramazan DANIŞ
Viral Hepat J 2013; 19: 140-143 DOI: 10.4274/Vhd.66375

Research Article

Which is More Important and Insidious in Dialysis Patients? Occult Hepatitis B or Occult Hepatitis C?
  • Özlem Zanapalıoğlu Gazel
  • Alper Şener
Viral Hepat J 2020; 26: 39-42 DOI: 10.4274/vhd.galenos.2019.2019.0032
Aspirin for Preventing Hemodialysis-associated Chronic Hepatitis C Infections
  • Tayibe BAL
  • Yusuf ÖNLEN
  • Selma İlkay ŞAHİN
  • Faruk Hilmi TURGUT
Viral Hepat J 2018; 24: 43-46 DOI: 10.4274/vhd.2018.0002
HBsAg, Anti-HBs, Anti-HCV and HIV Seroprevalence in Hemodialysis Patients in Elazığ Province
  • Gülden ESER KARLIDAĞ
  • Mehmet KÜÇÜKSU
  • Mustafa DEMİR
Viral Hepat J 2018; 24: 53-56 DOI: 10.4274/vhd.2018.0004
Occult Hepatitis B in Hemodialysis Patients
  • Pelin Adar
  • Şükran Köse
  • Bengü Tatar
Viral Hepat J 2019; 25: 88-91 DOI: 10.4274/vhd.galenos.2019.2018.0009
Efficacy of Direct-acting Antivirals in Hemodialysis Patients with Chronic Hepatitis C: A Real-life Retrospective Study
  • Nurten Nur Aydın
  • Firdevs Aksoy
  • İlknur Yavuz
  • Serap İskender
  • Arzu Altunçekiç Yıldırım
  • İlknur Esen Yıldız
  • İftihar Köksal
Viral Hepat J 2019; 25: 105-108 DOI: 10.4274/vhd.galenos.2019.2019.0025

Case Report

A Case of Acute Hepatitis C in a Hemodialysis Patient
  • Nuran SARI
  • Derya Özcan KANAT
  • Dilek ARMAN
  • Firdevs AKTAŞ
  • Fatma ULUTAN
Viral Hepat J 2008; 13: 40-44

Letter to Editor

Hepatitis B Virus and Hepatitis C Virus Seroprevalence in Hemodialysis Patients in Eskisehir Yunus Emre State Hospital
  • Pınar Korkmaz
  • Figen Çağlan Çevik
  • Nevil Aykın
  • Rüya Mutluay
  • Hakkı Mustafa Güldüren
  • Yeşim Alpay
  • Zühre Doğru Yaşar
  • Melahat Uğur
Viral Hepat J 2014; 20: 140-141 DOI: 10.4274/vhd.47955

Other

The Evaluation of Immune Responses That Occur After HBV Infection and HBV Vaccination in Hemodialysis Patients
  • Ismail Hamdi KARA
  • Ali SÜNER
  • Ali Kemal KADIROGLU
  • M.Emin YILMAZ
  • Bünyamin ISIKOGLU
Viral Hepat J 2003; 8: 0-0
Prevalance of HBsAg, Anti-HBs, Anti-HBc Total, Anti-HBc IgM, Anti-HCV andAnti-HAV IgG in Hemodialysis Patients
  • Ayten KADANALI
  • Suna PIRIMOGLU
  • Kemalettin ÖZDEN
Viral Hepat J 2004; 9: 41-45
Treatment of Chronic Hepatitis C with Alpha Interferon in Hemodialysis Patients
  • Fatih BESISIK
  • Salih TÜRKOGLU
  • Sabahattin KAYMAKOGLU
  • Mürvet BOGAZCI
  • Levent ERDEM
  • Mehmet SEVER
  • Alaattin YILDIZ
  • Selim GÜREL
  • Yilmaz ÇAKALOGLU
  • Atilla ÖKTEN
  • Selim BADUR
Viral Hepat J 1995; 1: 57-60
Serological Markers of Hepatitis B and Hepatitis D in Hemodialisis Patients
  • Haldun SÜMER
  • Tamer SANLIDAG
  • Zeynep SÜMER
  • Ömer POYRAZ
Viral Hepat J 1997; 3: 109-110
The Relationship of Hepatitis C Seroprevalence and Age, Sex, and Hemodialysis Time of Patients Undergoing Hemodialysis
  • Muhammet Güzel KURTOGLU
  • Hamza BOZKURT
  • Recep KESLI
  • Mustafa BERKTAS
Viral Hepat J 2006; 11: 142-147
Seroprevalence of Hepatitis E Virus in Hemodialysis Patients
  • Ilknur KALELI
  • Banu ÇETIN
  • Nural CEVAHIR
  • Hüseyin TURGUT
  • A. Nevzat YALÇIN
  • Filiz AKSIT
Viral Hepat J 1999; 5: 142-144
Effects of Hygienic Conditions on HEV Seroprevalence in Hemodialysis Patients
  • Irfan SENCAN
  • Idris SAHIN
  • Mustafa YILDIRIM
  • Oguz KARABAY
  • Davut ÖZDEMIR
Viral Hepat J 2003; 8: 143-147
ASSESSMENT OF HEPATITIS BAND C MARKERS IN CHRONIC HEMODIALYSIS PATIENTS
  • Irfan SENCAN
  • Idris SAHIN
  • Necati ÇATAKOGLU
  • Oguz ÜSKÜDAR
  • Zeynep BAHTIYAR
  • Mustafa YILDIRIM
Viral Hepat J 2002; 8: 463-466